Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools.

The purpose is to foster the commercialization of innovative

single cell analysis technologies for their broad use in biomedical research.

The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease.

Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured.

The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells.

A companion FOA to support STTR Grants is also available see PA-17-148
Related Programs

Environmental Health

Department of Health and Human Services


Oral Diseases and Disorders Research

Department of Health and Human Services


Research and Training in Complementary and Alternative Medicine

Department of Health and Human Services


Mental Health Research Grants

Department of Health and Human Services


Drug Abuse and Addiction Research Programs

Department of Health and Human Services


National Center for Advancing Translational Sciences

Department of Health and Human Services


Cancer Cause and Prevention Research

Department of Health and Human Services


Cancer Detection and Diagnosis Research

Department of Health and Human Services


Cancer Treatment Research

Department of Health and Human Services


Cancer Biology Research

Department of Health and Human Services


Cancer Control

Department of Health and Human Services


Arthritis, Musculoskeletal and Skin Diseases Research

Department of Health and Human Services


Diabetes, Digestive, and Kidney Diseases Extramural Research

Department of Health and Human Services


Biomedical Research and Research Training

Department of Health and Human Services


Vision Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: Not Available


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PA-17-147.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PA-17-147.html

Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV

Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:
FBOWebmaster@OD.NIH.GOV

Date Posted:
2017-02-01

Application Due Date:
2020-01-05

Archive Date:
2020-02-05


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Compassion Capital Fund | Federal Transit Employee Protection Certifications: Office of Labor-Management Standards | Assistance for Indian Children with Severe Disabilities | HUBZone Program | Alcohol Research Center Grants |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders